Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Promising Polyphenols in Parkinson's Disease Therapeutics

Singh A, Tripathi P, Yadawa AK, Singh S.

Neurochem Res. 2020 Aug;45(8):1731-1745. doi: 10.1007/s11064-020-03058-3. Epub 2020 May 27.

Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases

Krahn AI, Wells C, Drewry DH, Beitel LK, Durcan TM, Axtman AD.

ACS Chem Neurosci. 2020 Jul 1;11(13):1871-1886. doi: 10.1021/acschemneuro.0c00176. Epub 2020 Jun 11.

Integrated and patient-centred management of Parkinson's disease: a network model for reshaping chronic neurological care

Bloem BR, Henderson EJ, Dorsey ER, Okun MS, Okubadejo N, Chan P, Andrejack J, Darweesh SKL, Munneke M.

Lancet Neurol. 2020 Jul;19(7):623-634. doi: 10.1016/S1474-4422(20)30064-8. Epub 2020 May 25.

Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding

Meloni M, Puligheddu M, Sanna F, Cannas A, Farris R, Tronci E, Figorilli M, Defazio G, Carta M.

J Neurol Sci. 2020 Aug 15;415:116869. doi: 10.1016/j.jns.2020.116869. Epub 2020 Apr 29.

Parkinson's Disease: Available Clinical and Promising Omics Tests for Diagnostics, Disease Risk Assessment, and Pharmacotherapy Personalization

Trifonova OP, Maslov DL, Balashova EE, Urazgildeeva GR, Abaimov DA, Fedotova EY, Poleschuk VV, Illarioshkin SN, Lokhov PG.

Diagnostics (Basel). 2020 May 25;10(5):339. doi: 10.3390/diagnostics10050339.

Pearls and Oy-sters: Vitamin B(6) deficiency presenting with new-onset epilepsy and status epilepticus in a patient with Parkinson disease

Modica JS, Bonno D, Lizarraga KJ.

Neurology. 2020 Jun 16;94(24):e2605-e2607. doi: 10.1212/WNL.0000000000009647. Epub 2020 May 28.

In Silico and In Vivo Studies on Quercetin as Potential Anti-Parkinson Agent

Boyina HK, Geethakhrishnan SL, Panuganti S, Gangarapu K, Devarakonda KP, Bakshi V, Guggilla SR.

Adv Exp Med Biol. 2020;1195:1-11. doi: 10.1007/978-3-030-32633-3_1.

Olive Oil Polyphenols in Neurodegenerative Pathologies

Salis C, Papageorgiou L, Papakonstantinou E, Hagidimitriou M, Vlachakis D.

Adv Exp Med Biol. 2020;1195:77-91. doi: 10.1007/978-3-030-32633-3_12.

The Misfolding of Proteins

Argyrou A.

Adv Exp Med Biol. 2020;1195:249-254. doi: 10.1007/978-3-030-32633-3_33.

Is Rapid Eye Movement Sleep Behavior Disorder a Risk Factor for Impulse Control Disorder in Parkinson Disease?

Fantini ML, Fedler J, Pereira B, Weintraub D, Marques AR, Durif F.

Ann Neurol. 2020 Oct;88(4):759-770. doi: 10.1002/ana.25798. Epub 2020 Aug 14.

Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

Vitek JL, Jain R, Chen L, Tröster AI, Schrock LE, House PA, Giroux ML, Hebb AO, Farris SM, Whiting DM, Leichliter TA, Ostrem JL, San Luciano M, Galifianakis N, Verhagen Metman L, Sani S, Karl JA, Siddiqui MS, Tatter SB, Ul Haq I, Machado AG, Gostkowski M, Tagliati M, Mamelak AN, Okun MS, Foote KD, Moguel-Cobos G, Ponce FA, Pahwa R, Nazzaro JM, Buetefisch CM, Gross RE, Luca CC, Jagid JR, Revuelta GJ, Takacs I, Pourfar MH, Mogilner AY, Duker AP, Mandybur GT, Rosenow JM, Cooper SE, Park MC, Khandhar SM, Sedrak M, Phibbs FT, Pilitsis JG, Uitti RJ, Starr PA.

Lancet Neurol. 2020 Jun;19(6):491-501. doi: 10.1016/S1474-4422(20)30108-3. Epub 2020 May 26.

Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson's Disease

Henchcliffe C, Sarva H.

CNS Drugs. 2020 Jun;34(6):559-577. doi: 10.1007/s40263-020-00727-3.

Mesencephalic astrocyte-derived neurotrophic factor: A treatment option for parkinson's disease

Yang C, Gao Y.

Front Biosci (Landmark Ed). 2020 Jun 1;25(9):1718-1731. doi: 10.2741/4874.

Targeting mitochondrial calcium pathways as a potential treatment against Parkinson's disease

Dey K, Bazala MA, Kuznicki J.

Cell Calcium. 2020 Jul;89:102216. doi: 10.1016/j.ceca.2020.102216. Epub 2020 May 16.

Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?

Pellegrini C, Antonioli L, Calderone V, Colucci R, Fornai M, Blandizzi C.

Prog Neurobiol. 2020 Aug;191:101806. doi: 10.1016/j.pneurobio.2020.101806. Epub 2020 May 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias